Skip to main content
Day.News — Local News. Real Community.
SCOTT COUNTY DAY NEWS
Local News. Real Community.

State News

08/20/2026 · Scott County

Full Edition
FDA Approves Subcutaneous Lecanemab for Early Alzheimer's Treatment

FDA Approves Subcutaneous Lecanemab for Early Alzheimer's Treatment

The Food and Drug Administration has approved LEQEMBI IQLIK (lecanemab-irmb), a subcutaneous injection for early Alzheimer's disease. This formulation allows for at-home dosing, broadening administration options for patients.

08/21/2026
Read Story
Politics

U.S. Implements New Visa Restrictions Targeting Cybercrime, Sextortion

The U.S. government announced a new visa restriction policy on July 23, 2026, targeting individuals linked to cybercrime, including online investment scams and sextortion. The policy extends to immediate family members of those implicated. Officials cite online investment scams defrauding U.S. citizens of at least $10 billion in 2024.

08/21/2026

Health

Survey Identifies Generational Differences in Healthcare System Perceptions

A recent national survey reveals differences in how age groups perceive the U.S. healthcare system. Gen Z and Millennial voters more frequently identified systemic failures, especially regarding women's health services.

08/21/2026

Education

Middle School Reading Scores Decline for Lowest-Performing Students, NWEA Study Finds

A new study by NWEA, a K-12 assessment organization, reports a persistent decline in reading scores for the lowest-performing middle school students. The research identifies this trend as ongoing since 2020. The study also highlights state policies showing potential in addressing these educational outcomes.

08/21/2026

Business

Egan-Jones Report Details AI's Influence on Industries and Investment Risk

Egan-Jones released an analysis detailing how artificial intelligence and autonomous technologies reshape industries. The report outlines challenges to existing business models and new considerations for institutional investors and risk management.

08/21/2026

Health

FDA Approves Subcutaneous Leqembi Starting Dose for Alzheimer's Treatment

The FDA has approved a weekly subcutaneous starting dose for Leqembi, a drug for early Alzheimer's. This approval provides an alternative administration method for patients. The Alzheimer's Drug Discovery Foundation commented on the development.

08/19/2026

More State News

Sponsored

Advertisement

Advertisement

Advertisement